PharmedOut

She Died After Her Pacemaker Battery Failed. Its Maker Knew of Problems for Years. nytimes.com/2026/03/19/bus… via @NYTimes

Nursing homes falsely label patients schizophrenic to sedate them, OIG says washingtonpost.com/health/2026/03…

PharmedOut's Caroline Renko testifies at MD hearing: “Industry-funded disease awareness campaigns are vital for marketing expensive drugs... " "Marketing drugs prior to FDA approval is illegal. However, marketing diseases is not.” fiercepharma.com/marketing/prop…

A bill introduced in the Maryland legislature would require drugmakers to disclose ties to disease awareness campaigns. trib.al/ijeh6Ei

PharmedOut testified at a Maryland House Health Committee advocating for transparency around pharmaceutical marketing disguised as public health education. Read the @statnews coverage here: statnews.com/pharmalot/2026…

Great article by L. Cosgrove et al on the hasty approval of zuranolone for postpartum depression. Notes the U.S. is "the only country that has approved zuranolone and is also the only one of 41 OECD nations that does not mandate any paid family leave" pubmed.ncbi.nlm.nih.gov/41640203/

Dr. Adewole Adamson on Grail’s Cancer Detection Test inability to affect advanced cancer diagnoses: The study failed, he said. “End of story.” nytimes.com/2026/02/20/hea… via @NYTimes

The FDA is making a mistake in removing black box warnings from menopausal hormone therapy products. "Removing a boxed warning doesn’t make a drug safer — it just makes the risks easier to overlook." Read our full statement: bit.ly/PharmedOUTMHT

Dental surgeons are prescribing fewer opioids: pmc.ncbi.nlm.nih.gov/articles/PMC11…

PharmedOut's Bencivenga and Fugh-Berman describe the cyclical - and dangerous- overpromotion of menopausal hormone therapy statnews.com/2026/01/08/hor… via @statnews

Carl Elliott: | How can a professor keep a straight face while instructing a student not to cheat when both of them know that university administrators protect plagiarists and frauds? startribune.com/umn-professors…

Makary, RFK Jr. Exaggerate Chronic Disease Benefits of Menopausal Hormone Therapy - FactCheck.org factcheck.org/2025/12/makary…

The FDA's plan to remove warnings from labels of menopausal hormone therapy "may be the most damaging decision that this administration has made against public health", say Butler and Fugh-Berman in Kansas City Star op-ed: #storylink=cpyhttps://www.kansascity.com/opinion/readers-opinion/guest-commentary/article313297565.html" target="_blank" rel="nofollow noopener">kansascity.com/opinion/reader…

Fugh-Berman quoted in BMJ article: Menopausal hormone therapy "should not be used for disease prevention, and it should not be used to treat symptoms that are not associated with menopause. " Jennifer Block exposes Let’s Talk Menopause... bmj.com/content/391/bm…

New publication shines a light on who testifies at #FDA Advisory Committee meetings. "The FDA should consider strategies to solicit input from a broader array of stakeholders and mitigate COI among public participants." jamanetwork.com/journals/jamai…

"Drug samples aren’t charity...they are intended to influence prescribing. The best way to curb pharmaceutical marketing and support evidence-based, cost-effective treatments is to ban drug samples." Butler et. al in @Health_Affairs healthaffairs.org/content/forefr…

“The direction of travel is clear: Pharma is moving closer to the patient.” Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers? | PharmExec pharmexec.com/view/pharma-di…

Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade. - WSJ wsj.com/health/wellnes…

Big Pharma’s Dark Money Scores $8 Billion Bonanza levernews.com/big-pharmas-da…

More evidence that ibuprofen and acetaminophen are better than opioids for dental pain... ihttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2841046